A groundbreaking specimen transport system that enriches samples en-route to the lab, ensuring significant cost savings and faster diagnoses.
Explore
REINVENTING AN 85 YEAR-OLD SYSTEM
Today, 1 out of every 5 samples is misdiagnosed because samples often arrive to the lab already dead. LabReady re-imagines specimen transport by protecting and nurturing samples before they get to the lab.
MODERNIZING YOUR LAB
Since LabReady samples arrive at your lab enriched, all you need to do is run them for diagnosis. This huge time-saver means you can improve your lab’s workflow, increase throughput, and deliver faster diagnoses.
TemperatureIntegrity
Enrichment DuringTransport
Cold-ChainElimination
Lab CultureReady
TemperatureIntegrity
Enrichment DuringTransport
Cold-ChainElimination
Lab CultureReady
Enrichment During Transport
Temperature Integrity
Eliminates Cold-Chain Costs
Lab Culture Ready
By integrating our Specimen Multiplier Technology™ into a transport system, we’vecreated an entirely new method of faster, morereliable diagnoses when it is most critical.
It's not a new lab procedure. It's the first fully integrated specimen. enrichment transport system.
By integrating our Specimen Multiplier Technology™ into a transport system, we’ve created an entirely new method of faster, more reliable diagnoses when it is most critical.
FOR PATIENTS
LabReady’s Group B Strep product is the first in our line of women’s health diagnostics that helps avoid life-threatening complications and expensive consequences for mothers and their babies.
PatientsWe’ll be in touch soon.
In the mean time learn more about LabReady’s mission to decrease global infection mortality.
Labready MissionIf you’d like to chat about LabReady in more detail, complete this form and we’ll get back to you.
† LabReady is currently under review by the FDA as a Class 1 non-exempt medical device,
has not been cleared for medical use in any market, and is not currently intended to be used in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease.
† LabReady is currently under review by the FDA as a Class 1 non-exempt medical device,
has not been cleared for medical use in any market, and is not currently intended to be used in the diagnosis of
disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease.
† LabReady is currently under review by the FDA as a Class 1 non-exempt medical device, has not been cleared for medical use in any market, and is not currently intended to be used in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease.